Literature DB >> 25394302

The significance for epidemiological studies anti-measles antibody detection examined by enzyme immunoassay (EIA) and plaque reduction neutralization test (PRNT).

Joanna Siennicka, Agnieszka Częścik, Agnieszka Trzcińska.   

Abstract

The paper discusses the role of anti-measles antibodies for protection and significance for epidemiological studies determination of antibodies by different serological methods. The comparison of anti-measles virus antibodies levels measured by enzyme immunoassay (EIA) and Plaque Reduction Neutralization Test (PRNT) was described. It was found that the 200 mIU/ml of anti-measles activity measured by PRNT (level protection against symp- tomatic disease) is equivalent of 636 mIU/ml measured by EIA (Enzygnost®Anti-Measles Virus/IgG, Simens).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25394302

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  4 in total

1.  Do Australian immunoglobulin products meet international measles antibody titer standards?

Authors:  Megan K Young; Joseph Bertolini; Pushpa Kotharu; Darryl Maher; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2016-10-20       Impact factor: 3.452

2.  Measles hepatitis in a vaccinated liver transplant recipient: case report and review of literature.

Authors:  Syed Adnan Mohiuddin; Muna AlMaslamani; Samar Hashim; Hanfa Karim Panthalayinitharayil; Saad Rashid Alkaabi; Abdulwahab Abdulwahab; Moutaz Derbala
Journal:  Clin Case Rep       Date:  2017-04-20

3.  Measles seroprevalence after reactive vaccination campaigns during the 2015 measles outbreak in four health zones of the former Katanga Province, Democratic Republic of Congo.

Authors:  Patrick Keating; Antonio Isidro Carrion Martin; Alexandre Blake; Pauline Lechevalier; Florent Uzzeni; Etienne Gignoux; Chibuzo Okonta; Céline Langendorf; Sheilagh Smit; Steve Ahuka; Melinda Suchard; Elizabeth Pukuta; Marie-Amélie Degail; Lisa Hansen; Jerry Kibanza-Kyungu; Iza Ciglenecki; Sandra Cohuet
Journal:  BMC Public Health       Date:  2019-08-22       Impact factor: 3.295

4.  Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies.

Authors:  Niko Kohmer; Holger F Rabenau; Sandra Ciesek; Bernhard K Krämer; Uwe Göttmann; Christine Keller; Daniela Rose; Carsten Blume; Michael Thomas; Alexander Lammert; Anne Lammert
Journal:  Nephrol Dial Transplant       Date:  2022-05-25       Impact factor: 7.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.